Ignite Creation Date:
2025-12-25 @ 12:26 AM
Ignite Modification Date:
2025-12-25 @ 10:32 PM
Study NCT ID:
NCT01333358
Status:
UNKNOWN
Last Update Posted:
2011-04-25
First Post:
2011-04-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluating Alemtuzumab as a Treatment in Stabilizing Neurocognitive Function In Relapsing Remitting Multiple Sclerosis Patients
Sponsor:
Central Texas Neurology Consultants
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2013-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2014-03
Completion Date Type:
ESTIMATED
First Submit Date:
2011-04-08
First Submit QC Date:
None
Study First Post Date:
2011-04-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-04-22
Last Update Post Date:
2011-04-25
Last Update Post Date Type:
ESTIMATED